Spotlight Innovation (PK) Stock Price - STLT

0.00 (0.0%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Spotlight Innovation Inc New (PK) STLT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.0077 0.00 0.00 0.00 0.0077 16:00:04
Bid Price Ask Price Spread Spread % News
0.0077 0.021 0.0133 63.33% - -
Stock Trades Traded Volume Average Volume 52 Week Range
1 4 3,138 0.0035 - 0.034
Last Trade Time Type Quantity Stock Price Currency
14:14:28 4 $ 0.01245 USD

Spotlight Innovation (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 275.37k 35.76M 9.63M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
8.14k $ - 0.00% - -

more financials information »

Spotlight Innovation (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical STLT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00770.00770.00770.00771,1000.000.0%
1 Month0.00950.0210.00760.012467313,548-0.0018-18.95%
3 Months0.00450.0210.00450.01002378,4350.003271.11%
6 Months0.00560.0210.00350.006339616,2000.002137.5%
1 Year0.01250.0340.00350.007264811,775-0.0048-38.4%
3 Years0.37450.410.0020.108923725,759-0.3668-97.94%
5 Years1.251.750.0020.354739927,563-1.24-99.38%

Spotlight Innovation (PK) Description

Spotlight Innovation Inc. (OTCQB: STLT) acquires and develops proprietary therapies to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. The Company identifies in-licensing opportunities and manages product development through partnerships with universities, medical schools, contract research organizations (CROs), and contract manufacturing organizations (CMOs). At the appropriate stage of research and development the Company will endeavor to pursue product commercialization opportunities including, but not limited to, out-licensing and strategic partnerships with industry leaders.

Your Recent History
Spotlight ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.